HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Non-Hodgkin's lymphoma: patterns of relapse from complete remission after combination chemotherapy.

Abstract
An analysis of patterns of relapse from complete remission in patients with non-Hodgkin's lymphoma treated with combination chemotherapy has demonstrated differences between histologic subgroups. Patients with diffuse histiocytic lymphoma who achieved a histologically proven complete remission after 6 months of treatment without maintenance have remained disease-free whereas those with nodular poorly differentiated lymphocytic and diffuse well-differentiated lymphocytic lymphomas have demonstrated a pattern of continuous late recurrence. The initial sites of relapse from complete remission in lymphocytic lymphoma were lymph nodes and bone marrow which were involved prior to treatment. Aggressive attempts at remission induction appear warranted in patients with diffuse histiocytic lymphoma because of the potential for extended disease-free survival. Patients with nodular poorly differentiated lymphocytic lymphoma may benefit from the use of maintenance chemotherapy, or radiotherapy to regions of previously known involvement after initiation of remission with chemotherapy.
AuthorsP S Schein, B A Chabner, G P Canellos, R C Young, V T DeVita Jr
JournalCancer (Cancer) Vol. 35 Issue 2 Pg. 354-7 (Feb 1975) ISSN: 0008-543X [Print] United States
PMID1089470 (Publication Type: Journal Article)
Chemical References
  • Antineoplastic Agents
  • Procarbazine
  • Mechlorethamine
  • Vincristine
  • Cyclophosphamide
  • Prednisone
Topics
  • Antineoplastic Agents (therapeutic use)
  • Bone Marrow
  • Cyclophosphamide (therapeutic use)
  • Drug Therapy, Combination
  • Humans
  • Lymph Nodes
  • Lymphoma, Large B-Cell, Diffuse (drug therapy)
  • Lymphoma, Non-Hodgkin (drug therapy)
  • Mechlorethamine (therapeutic use)
  • Neoplasm Recurrence, Local
  • Prednisone (therapeutic use)
  • Procarbazine (therapeutic use)
  • Prognosis
  • Remission, Spontaneous
  • Time Factors
  • Vincristine (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: